Ireland - English - HPRA (Health Products Regulatory Authority)

livisto int'l, s.l. - colistin sulfate - oral solution - 5,000,000 iu/ml - colistin - bovine, fowl - chicken, fowl - turkey, ovine, porcine - antibiotics

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - colistin sulfate (unii: wp15dxu577) (colistin - unii:z67x93hjg1), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), thonzonium bromide (unii: ji2b19cr0r) (thonzonium bromide - unii:ji2b19cr0r), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - colistin 3 mg in 1 ml - cortisporin® -tc otic suspension is indicated for the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics; and for the treatment of infections of mastoidectomy and fenestration cavities, caused by organisms susceptible to the antibiotics. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components. this product should not be used if the external auditory canal disorder is suspected or known to be due to cutaneous viral infection (e.g., herpes simplex virus or varicella zoster virus).

United States - English - NLM (National Library of Medicine)

endo pharmaceuticals inc. - colistin sulfate (unii: wp15dxu577) (colistin - unii:z67x93hjg1), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), thonzonium bromide (unii: ji2b19cr0r) (thonzonium - unii:z05ze98fv8), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - colistin 3 mg in 1 ml - coly-mycin® s otic is indicated for the treatment of superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics; and for the treatment of infections of mastoidectomy and fenestration cavities, caused by organisms susceptible to the antibiotics. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components. this product should not be used if the external auditory canal disorder is suspected or known to be due to cutaneous viral infection (e.g., herpes simplex virus or varicella zoster virus).

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dechra veterinary products sa-nv - colistin sulfate 400000 iu/ml - solution for use in drinking water/milk - colistin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

v.m.d. sa-nv - colistin sulfate 1000000 iu/ml - solution for injection - 1 mio iu/ml - colistin sulfate 1000000 iu/ml - colistin - cattle

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - gentamicin sulfate 10 mg/ml (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) - solution for infusion - 10 mg/ml - active: gentamicin sulfate 10 mg/ml (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) excipient: disodium edetate dihydrate sodium hydroxide sulfuric acid water for injection - dbl™ gentamicin injection bp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa proteus species (indole positive and indole negative) escherichia coli klebsiella - enterobacter - serratia species staphylococcus species (coagulase positive and coagulase negative) dbl™ gentamicin injection bp should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia respiratory tract infections infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis urinary tract infections (recurrent, complicated) dbl™ gentamicin injection bp is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. dbl™ gentamicin injection bp may be considered as initial therapy in suspected or confirmed gram negative infections and therapy may be instituted before obtained results of susceptibility testing. if anaerobic organisms are suspected, additional antimicrobial therapy should be added to the gentamicin regime.

Ireland - English - HPRA (Health Products Regulatory Authority)

livisto int'l, s.l. - colistin sulfate - oral solution - 5,000,000 international unit(s)/millilitre - colistin - cattle, chickens, pigs, sheep, turkeys - antibiotics

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - colistin sulfate (unii: wp15dxu577) (colistin - unii:z67x93hjg1) - colistin 3 mg in 1 ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - heparin sodium 10 iu/ml - solution for injection - 50 iu/5ml - active: heparin sodium 10 iu/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prodivet pharmaceuticals sa-nv - colistin sulfate 2,5 mg/ml - solution for injection - colistin sulfate 50 iu/ml - colistin - pig